Twist Bioscience Corporation (TWST)
TWST Stock Price Chart
Explore Twist Bioscience Corporation interactive price chart. Choose custom timeframes to analyze TWST price movements and trends.
TWST Company Profile
Discover essential business fundamentals and corporate details for Twist Bioscience Corporation (TWST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
31 Oct 2018
Employees
923.00
Website
https://www.twistbioscience.comCEO
Emily Marine Leproust
Description
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
TWST Financial Timeline
Browse a chronological timeline of Twist Bioscience Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Aug 2026
EPS estimate is -$0.50, while revenue estimate is $114.55m.
Earnings released on 4 May 2026
EPS came in at -$0.71 falling short of the estimated -$0.49 by -44.90%, while revenue for the quarter reached $110.72m , beating expectations by +2.85%.
Earnings released on 2 Feb 2026
EPS came in at -$0.50 falling short of the estimated -$0.48 by -4.17%, while revenue for the quarter reached $103.70m , beating expectations by +1.78%.
Earnings released on 14 Nov 2025
EPS came in at -$0.45 surpassing the estimated -$0.50 by +10.00%, while revenue for the quarter reached $99.01m , beating expectations by +1.65%.
Earnings released on 4 Aug 2025
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%, while revenue for the quarter reached $96.06m , missing expectations by -1.35%.
Earnings released on 5 May 2025
EPS came in at -$0.66 falling short of the estimated -$0.56 by -17.86%, while revenue for the quarter reached $92.79m , missing expectations by -2.72%.
Earnings released on 3 Feb 2025
EPS came in at -$0.53 surpassing the estimated -$0.62 by +14.52%, while revenue for the quarter reached $88.71m , beating expectations by +2.03%.
Earnings released on 18 Nov 2024
EPS came in at -$0.59 surpassing the estimated -$0.71 by +17.35%, while revenue for the quarter reached $84.71m , beating expectations by +2.41%.
Earnings released on 2 Aug 2024
EPS came in at -$0.86 falling short of the estimated -$0.79 by -8.86%, while revenue for the quarter reached $81.46m , missing expectations by -0.90%.
Earnings released on 2 May 2024
EPS came in at -$0.79 surpassing the estimated -$0.84 by +5.95%, while revenue for the quarter reached $75.30m , missing expectations by -2.71%.
Earnings released on 2 Feb 2024
EPS came in at -$0.75 surpassing the estimated -$0.80 by +6.25%, while revenue for the quarter reached $71.50m , beating expectations by +5.78%.
Earnings released on 17 Nov 2023
EPS came in at -$0.81 surpassing the estimated -$0.94 by +13.83%, while revenue for the quarter reached $66.95m , beating expectations by +5.68%.
Earnings released on 4 Aug 2023
EPS came in at -$1.01 surpassing the estimated -$1.14 by +11.40%, while revenue for the quarter reached $63.74m , beating expectations by +5.29%.
Earnings released on 5 May 2023
EPS came in at -$1.06 surpassing the estimated -$1.09 by +2.75%, while revenue for the quarter reached $60.18m , beating expectations by +6.16%.
Earnings released on 3 Feb 2023
EPS came in at -$0.74 surpassing the estimated -$1.09 by +32.11%, while revenue for the quarter reached $54.24m , missing expectations by -0.31%.
Earnings released on 18 Nov 2022
EPS came in at -$0.91 surpassing the estimated -$1.28 by +28.91%, while revenue for the quarter reached $57.31m , beating expectations by +0.72%.
Earnings released on 5 Aug 2022
EPS came in at -$1.08 surpassing the estimated -$1.30 by +16.92%, while revenue for the quarter reached $56.11m , beating expectations by +7.78%.
Earnings released on 5 May 2022
EPS came in at -$1.24 surpassing the estimated -$1.26 by +1.59%, while revenue for the quarter reached $48.13m .
Earnings released on 4 Feb 2022
EPS came in at -$0.91 surpassing the estimated -$1.08 by +15.74%, while revenue for the quarter reached $42.02m , missing expectations by -9.60%.
Earnings released on 22 Nov 2021
EPS came in at -$0.84 falling short of the estimated -$0.80 by -5.00%, while revenue for the quarter reached $37.95m , missing expectations by -1.04%.
Earnings released on 6 Aug 2021
EPS came in at -$0.82 falling short of the estimated -$0.76 by -7.89%, while revenue for the quarter reached $35.02m , beating expectations by +8.55%.
TWST Stock Performance
Access detailed TWST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
